Skip to main content
Top
Published in: Journal of Neural Transmission 12/2012

01-12-2012 | Dementias - Short communication

Positive argument for debate in J Neural Transmission: Alzheimer’s disease: are we intervening too late? Yes, by years if not decades

Authors: Thomas B. Shea, Ruth Remington

Published in: Journal of Neural Transmission | Issue 12/2012

Login to get access

Abstract

The ongoing debate as to whether we are or are not early enough in treatment for Alzheimer’s disease presents distinct vantage points. Points expressed range from stressing the need for early preventive measures to highlighting the failure of “alternative” therapies, and concluding that we are unfortunately doing all that we can at present. Herein, we stress the worth of nutritional intervention, and review why such studies are often inherently compromised. We conclude that considerable education is needed to advance lifestyle modifications early enough to obtain their optimal effect, and instead of positioning “classical” interventions against “alternative” interventions, the combinations of both may impart maximal benefit. The introduction of novel detection methods at the earliest indications of cognitive impairment may provide a window of opportunity for initiation of preventative approaches.
Literature
go back to reference Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB (2011) Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment? Br J Clin Pharmacol 71:365–376PubMedCrossRef Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB (2011) Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment? Br J Clin Pharmacol 71:365–376PubMedCrossRef
go back to reference Ames D (2011) Negative argument for debate with V. O. Emery for J Neural Transmission: Alzheimer’s disease: are we intervening too late? No we are not. Con J Neural Transm 118:1379–1381CrossRef Ames D (2011) Negative argument for debate with V. O. Emery for J Neural Transmission: Alzheimer’s disease: are we intervening too late? No we are not. Con J Neural Transm 118:1379–1381CrossRef
go back to reference Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, Fezeu L, Hercberg S, Galan P (2011) Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr 94:278–286PubMedCrossRef Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, Fezeu L, Hercberg S, Galan P (2011) Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr 94:278–286PubMedCrossRef
go back to reference Ballard C, Khan Z, Clack H, Corbett A (2011) Nonpharmacological treatment of Alzheimer disease. Can J Psychiatry 56:589–595PubMed Ballard C, Khan Z, Clack H, Corbett A (2011) Nonpharmacological treatment of Alzheimer disease. Can J Psychiatry 56:589–595PubMed
go back to reference Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G (2005) Integrated treatment approach improves cognitive function in demented and clinically depressed patients. Am J Alzheimers Dis Other Demen 20:21–26PubMedCrossRef Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G (2005) Integrated treatment approach improves cognitive function in demented and clinically depressed patients. Am J Alzheimers Dis Other Demen 20:21–26PubMedCrossRef
go back to reference Chan A, Tchantchou F, Graves V, Rozen R, Shea TB (2008a) Dietary and genetic compromise in folate availability reduces acetylcholine and cognitive performance: critical role of S-adenosylmethionine. J Health Nutr Aging 12:252–261CrossRef Chan A, Tchantchou F, Graves V, Rozen R, Shea TB (2008a) Dietary and genetic compromise in folate availability reduces acetylcholine and cognitive performance: critical role of S-adenosylmethionine. J Health Nutr Aging 12:252–261CrossRef
go back to reference Chan A, Paskavitz J, Remington R, Shea TB (2008b) Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer’s disease: a one-year open-label pilot study with a 16-month extension. Am J Alzheimer Dis Other Dement 23:571–585CrossRef Chan A, Paskavitz J, Remington R, Shea TB (2008b) Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer’s disease: a one-year open-label pilot study with a 16-month extension. Am J Alzheimer Dis Other Dement 23:571–585CrossRef
go back to reference Chan A, Tchantchou F, Rogers EJ, Shea TB (2009) Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine. J Neurochem 110:831–836PubMedCrossRef Chan A, Tchantchou F, Rogers EJ, Shea TB (2009) Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine. J Neurochem 110:831–836PubMedCrossRef
go back to reference Chan A, Lepore A, Kotoya E, Zemianek J, Remington R, Shea TB (2010) Efficacy of a vitamin/nutriceutical formulation on cognitive speed and recall in adults with no known or suspected dementia. J Nutri Health Aging 14:224–230CrossRef Chan A, Lepore A, Kotoya E, Zemianek J, Remington R, Shea TB (2010) Efficacy of a vitamin/nutriceutical formulation on cognitive speed and recall in adults with no known or suspected dementia. J Nutri Health Aging 14:224–230CrossRef
go back to reference Connelly PJ, Prentice NP, Cousland G, Bonham J (2008) A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer’s disease. Int J Geriatr Psychiatry 23:155–160PubMedCrossRef Connelly PJ, Prentice NP, Cousland G, Bonham J (2008) A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer’s disease. Int J Geriatr Psychiatry 23:155–160PubMedCrossRef
go back to reference Cornelli U (2010) Treatment of Alzheimer’s disease with a cholinesterase inhibitor combined with antioxidants. Neurodegener Dis 7:193–202PubMedCrossRef Cornelli U (2010) Treatment of Alzheimer’s disease with a cholinesterase inhibitor combined with antioxidants. Neurodegener Dis 7:193–202PubMedCrossRef
go back to reference Daviglus ML, Plassman BL, Pirzada A, Bell CC, Bowen PE, Burke JR, Connolly ES Jr, Dunbar-Jacob JM, Granieri EC, McGarry K, Patel D, Trevisan M, Williams JW Jr (2011) Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol 68:1185–1190PubMedCrossRef Daviglus ML, Plassman BL, Pirzada A, Bell CC, Bowen PE, Burke JR, Connolly ES Jr, Dunbar-Jacob JM, Granieri EC, McGarry K, Patel D, Trevisan M, Williams JW Jr (2011) Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol 68:1185–1190PubMedCrossRef
go back to reference de Sousa OL, Amaral TF (2012) Three-week nutritional supplementation effect on long-term nutritional status of patients with mild Alzheimer disease. Alzheimer Dis Assoc Disord 26:119–123 de Sousa OL, Amaral TF (2012) Three-week nutritional supplementation effect on long-term nutritional status of patients with mild Alzheimer disease. Alzheimer Dis Assoc Disord 26:119–123
go back to reference Dhitavat S, Ortiz D, Rogers E, Rivera E, Shea TB (2005) Folate, vitamin E and acetyl-l-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid beta. Brain Res 1061:114–117PubMedCrossRef Dhitavat S, Ortiz D, Rogers E, Rivera E, Shea TB (2005) Folate, vitamin E and acetyl-l-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid beta. Brain Res 1061:114–117PubMedCrossRef
go back to reference Dubois B, Feldman HH, Jacova C, Dekosy ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’Brien K, Paquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS—ADRDA criteria. Lancet Neurol 6:734–746PubMedCrossRef Dubois B, Feldman HH, Jacova C, Dekosy ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’Brien K, Paquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS—ADRDA criteria. Lancet Neurol 6:734–746PubMedCrossRef
go back to reference Durga J, van Boxtel MP, Schouten EG et al (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369:208–216PubMedCrossRef Durga J, van Boxtel MP, Schouten EG et al (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369:208–216PubMedCrossRef
go back to reference Ellison M, Thomas J, Patterson A (2004) A critical evaluation of the relationship between serum vitamin B12, folate and total homocysteine with cognitive impairment in the elderly. J Ji Mitr Doetet 17:371–383 Ellison M, Thomas J, Patterson A (2004) A critical evaluation of the relationship between serum vitamin B12, folate and total homocysteine with cognitive impairment in the elderly. J Ji Mitr Doetet 17:371–383
go back to reference Emery VO (2011) Alzheimer disease: are we intervening too late? Pro J Neural Transm 118:1361–1378CrossRef Emery VO (2011) Alzheimer disease: are we intervening too late? Pro J Neural Transm 118:1361–1378CrossRef
go back to reference Fuso A, Cavallaro RA, Zampelli A, D’Anselmi F, Piscopo P, Confaloni A, Scarpa S (2007) Gamma-secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J Alzheimer Dis 11:275–290 Fuso A, Cavallaro RA, Zampelli A, D’Anselmi F, Piscopo P, Confaloni A, Scarpa S (2007) Gamma-secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J Alzheimer Dis 11:275–290
go back to reference Fuso A, Nicolia V, Ricceri L, Cavallaro RA, Isopi E, Mangia F, Fiorenza MT, Scarpa S (2012) S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging 33:1482e1–1482e16 Fuso A, Nicolia V, Ricceri L, Cavallaro RA, Isopi E, Mangia F, Fiorenza MT, Scarpa S (2012) S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging 33:1482e1–1482e16
go back to reference Kang JH, Cook N, Manson J, Buring JE, Grodstein F (2006) A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 166:2462–2468PubMedCrossRef Kang JH, Cook N, Manson J, Buring JE, Grodstein F (2006) A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 166:2462–2468PubMedCrossRef
go back to reference Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F (2008) A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 88:1602–1610PubMedCrossRef Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F (2008) A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 88:1602–1610PubMedCrossRef
go back to reference Kroner Z (2009) The relationship between Alzheimer’s disease and diabetes: type 3 diabetes? Altern Med Rev 14:373–379PubMed Kroner Z (2009) The relationship between Alzheimer’s disease and diabetes: type 3 diabetes? Altern Med Rev 14:373–379PubMed
go back to reference LaMonte MJ, Blair SN, Church TS (2005) Physical activity and diabetes prevention. J Appl Physiol 99:1205–1213PubMedCrossRef LaMonte MJ, Blair SN, Church TS (2005) Physical activity and diabetes prevention. J Appl Physiol 99:1205–1213PubMedCrossRef
go back to reference Lee S, Lemere CA, Frost JL, Shea TB (2011) Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice. J Alzheimers Dis 28:423–431 Lee S, Lemere CA, Frost JL, Shea TB (2011) Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice. J Alzheimers Dis 28:423–431
go back to reference Lopez OL, McDade E, Riverol M, Becker JT (2011) Evolution of the diagnostic criteria for degenerative and cognitive disorders. Curr Opin Neurol 24:532–541PubMedCrossRef Lopez OL, McDade E, Riverol M, Becker JT (2011) Evolution of the diagnostic criteria for degenerative and cognitive disorders. Curr Opin Neurol 24:532–541PubMedCrossRef
go back to reference Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A (2004) Vitamin B12 and folate depletion in cognition: a review. Neurol India 52:310–318PubMed Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A (2004) Vitamin B12 and folate depletion in cognition: a review. Neurol India 52:310–318PubMed
go back to reference Morris MC, Tangney CC (2011) A potential design flaw of randomized trials of vitamin supplements. JAMA 305:1348–1349PubMedCrossRef Morris MC, Tangney CC (2011) A potential design flaw of randomized trials of vitamin supplements. JAMA 305:1348–1349PubMedCrossRef
go back to reference Okosun IS, Davis-Smith M, Seale JP (2012) Awareness of diabetes risks is associated with healthy lifestyle behavior in diabetes free American adults: evidence from a nationally representative sample. Prim Care Diabetes 6:87–94 Okosun IS, Davis-Smith M, Seale JP (2012) Awareness of diabetes risks is associated with healthy lifestyle behavior in diabetes free American adults: evidence from a nationally representative sample. Prim Care Diabetes 6:87–94
go back to reference Panza F, Frisardi V, Capurso C, D’Introno A, Colacicco AM, Vendemiale G, Capurso A, Solfrizzi V (2009) Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer’s disease. J Alzheimers Dis 16:467–470PubMed Panza F, Frisardi V, Capurso C, D’Introno A, Colacicco AM, Vendemiale G, Capurso A, Solfrizzi V (2009) Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer’s disease. J Alzheimers Dis 16:467–470PubMed
go back to reference Planel E, Miyasaka T, Launey T, Chui DH, Tanemura K, Sato S, Murayama O, Ishiguro K, Tatebayashi Y, Takashima A (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer’s disease. J Neurosci 24:2401–2411PubMedCrossRef Planel E, Miyasaka T, Launey T, Chui DH, Tanemura K, Sato S, Murayama O, Ishiguro K, Tatebayashi Y, Takashima A (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer’s disease. J Neurosci 24:2401–2411PubMedCrossRef
go back to reference Qi L, Hu FB, Hu G (2008) Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med 8:519–532PubMedCrossRef Qi L, Hu FB, Hu G (2008) Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med 8:519–532PubMedCrossRef
go back to reference Remington R, Chan A, Shea TB (2009) Efficacy of a vitamin/nutriceutical formulation for moderate to late-stage Alzheimer’s disease: a placebo-controlled pilot study. Am J Alzheimer Dis Other Dement 24:27–33CrossRef Remington R, Chan A, Shea TB (2009) Efficacy of a vitamin/nutriceutical formulation for moderate to late-stage Alzheimer’s disease: a placebo-controlled pilot study. Am J Alzheimer Dis Other Dement 24:27–33CrossRef
go back to reference Rivière S, Gillette-Guyonnet S, Voisin T, Reynish E, Andrieu S, Lauque S, Salva A, Frisoni G, Nourhashemi F, Micas M, Vellas B (2001) A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer’s disease. J Nutr Health Aging 5:295–299PubMed Rivière S, Gillette-Guyonnet S, Voisin T, Reynish E, Andrieu S, Lauque S, Salva A, Frisoni G, Nourhashemi F, Micas M, Vellas B (2001) A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer’s disease. J Nutr Health Aging 5:295–299PubMed
go back to reference Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ (2007) Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J Am Diet Assoc 107:1322–1332PubMedCrossRef Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ (2007) Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J Am Diet Assoc 107:1322–1332PubMedCrossRef
go back to reference Shea TB, Chan A (2008) S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer’s disease. J Alzheimer Dis 13:67–70 Shea TB, Chan A (2008) S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer’s disease. J Alzheimer Dis 13:67–70
go back to reference Solfrizzi V, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, D’Onofrio G, Addante F, Sancarlo D, Cascavilla L, Pilotto A, Panza F (2011a) Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res 8:520–542PubMedCrossRef Solfrizzi V, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, D’Onofrio G, Addante F, Sancarlo D, Cascavilla L, Pilotto A, Panza F (2011a) Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res 8:520–542PubMedCrossRef
go back to reference Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A (2011b) Diet and Alzheimer’s disease risk factors or prevention: the current evidence. Expert Rev Neurother 11:677–708PubMedCrossRef Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A (2011b) Diet and Alzheimer’s disease risk factors or prevention: the current evidence. Expert Rev Neurother 11:677–708PubMedCrossRef
go back to reference Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedCrossRef Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedCrossRef
go back to reference Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease—is this type 3 diabetes? J Alzheimers Dis 7:63–80 Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease—is this type 3 diabetes? J Alzheimers Dis 7:63–80
go back to reference Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC (2007) Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer’s disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 29:2204–2214PubMedCrossRef Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC (2007) Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer’s disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 29:2204–2214PubMedCrossRef
go back to reference Vellas B, Lauque S, Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashémi F, Cantet C, Ousset PJ, Grandjean H, REAL.FR Group (2005) Impact of nutritional status on the evolution of Alzheimer’s disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging 9:75–80PubMed Vellas B, Lauque S, Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashémi F, Cantet C, Ousset PJ, Grandjean H, REAL.FR Group (2005) Impact of nutritional status on the evolution of Alzheimer’s disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging 9:75–80PubMed
go back to reference Werder SF (2010) Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat 6:159–195PubMedCrossRef Werder SF (2010) Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat 6:159–195PubMedCrossRef
go back to reference Wollen KA (2010) Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners Alt. Med Rev 15:226–244 Wollen KA (2010) Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners Alt. Med Rev 15:226–244
go back to reference Zawia NH, Lahiri DK, Cardozo-Pelaez (2009) Epigenetics, oxidative stress and Alzheimer’s disease. Free Rad Biol Med 46:1241–1249 Zawia NH, Lahiri DK, Cardozo-Pelaez (2009) Epigenetics, oxidative stress and Alzheimer’s disease. Free Rad Biol Med 46:1241–1249
go back to reference Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G (2004) Oxidative stress signaling in Alzheimer’s disease. Brain Res 1000:32–39PubMedCrossRef Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G (2004) Oxidative stress signaling in Alzheimer’s disease. Brain Res 1000:32–39PubMedCrossRef
Metadata
Title
Positive argument for debate in J Neural Transmission: Alzheimer’s disease: are we intervening too late? Yes, by years if not decades
Authors
Thomas B. Shea
Ruth Remington
Publication date
01-12-2012
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 12/2012
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-012-0849-0

Other articles of this Issue 12/2012

Journal of Neural Transmission 12/2012 Go to the issue

Basic Neurosciences, Genetics and Immunology - Original Article

Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture

Neurology and Preclinical Neurological Studies - Short communication

The history of the research of iron in parkinsonian substantia nigra

Psychiatry and Preclinical Psychiatric Studies - Rapid communication

Alcohol dependence in same-sex and opposite-sex twins